Maurice Swanson, Ph.D., Professor of Molecular Genetics and Microbiology at University of Florida, Gainesville, and a team of researchers have found that the muscleblind-like 2 (MBNL2) protein in the central nervous system (CNS) may be responsible for the neurological impacts of myotonic dystrophy
Myotonic dystrophy symptoms tend to worsen gradually over several decades. While no treatment exists that slows the progression of myotonic dystrophy, management of its symptoms can greatly improve quality of life. Taking steps early to prevent or treat problems as they come up can help avert complications.
The congenital and childhood-onest of DM appear earlier in life with more severe symptoms. Therefore they present more and different management challenges than the adult onset forms of the condition. Pregnancy in affected mothers poses serious complications for both the mother and the newborn, often requiring intensive intervention.